Old Web
English
Sign In
Acemap
>
authorDetail
>
M. Pavilack
M. Pavilack
AstraZeneca
Medicine
General surgery
in patient
Oncology
egfr tkis
4
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P2.16-37 Impact of Brain Metastases on Healthcare Utilisation and Costs in Patients with NSCLC Treated with EGFR-TKIs
2019
Journal of Thoracic Oncology
D. Subramaniam
M. Pavilack
H. Huo
R Shenolikar
A. Kong
M. Moynihan
E. Marchlewicz
C. Larson
Show All
Source
Cite
Save
Citations (0)
MA15.11 Real World Biomarker Testing and Treatment Patterns in Patients with Advanced NSCLC Receiving EGFR-TKIs
2018
Journal of Thoracic Oncology
Anne C. Chiang
Ancilla Fernandes
M. Pavilack
J. Wu
François Laliberté
Mei Sheng Duh
N. Chehab
J. Subramanian
Show All
Source
Cite
Save
Citations (9)
P2.15-26 Rates and Economic Burden of Adverse Events in Patients With Metastatic NSCLC Treated with EGFR-TKIs
2018
Journal of Thoracic Oncology
J. Subramanian
François Laliberté
Ancilla Fernandes
M. Pavilack
Philippe Jacques
Mei Sheng Duh
Show All
Source
Cite
Save
Citations (0)
OA10.01 Patient Preferences for Tyrosine Kinase Inhibitor Treatments for EGFR Mutation Positive Metastatic NSCLC
2018
Journal of Thoracic Oncology
J. Bridges
M. De La Cruz
M. Pavilack
Emuella Flood
Ellen M. Janssen
N. Chehab
Ancilla Fernandes
Show All
Source
Cite
Save
Citations (0)
1